Literature DB >> 9914862

Neural mechanisms in nitric-oxide-deficient hypertension.

M Sander1, R G Victor.   

Abstract

Nitric oxide is hypothesized to be an inhibitory modulator of central sympathetic nervous outflow, and deficient neuronal nitric oxide production to cause sympathetic overactivity, which then contributes to nitric-oxide-deficient hypertension. The biochemical and neuroanatomical basis for this concept revolves around nitric oxide modulation of glutamatergic neurotransmission within brainstem vasomotor centers. The functional consequence of neuronal nitric oxide in blood pressure regulation is, however, marked by an apparent conflict in the literature. On one hand, conscious animal studies using sympathetic blockade suggest a significant role for neuronal nitric oxide deficiency in the development of nitric-oxide-deficient hypertension, and on the other hand, there is evidence against such a role derived from 'knock-out' mice lacking nitric-oxide synthase 1, the major source of neuronal nitric oxide.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Substances:

Year:  1999        PMID: 9914862     DOI: 10.1097/00041552-199901000-00011

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  6 in total

1.  Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology.

Authors:  Nayaab S Khan; Chi Young Song; Brett L Jennings; Anne M Estes; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

2.  Tetrahydrobiopterin ameliorates the exaggerated exercise pressor response in patients with chronic kidney disease: a randomized controlled trial.

Authors:  Ann M Lin; Peizhou Liao; Erin C Millson; Arshed A Quyyumi; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

3.  Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans.

Authors:  Colin N Young; James P Fisher; Kevin M Gallagher; Adam Whaley-Connell; Kunal Chaudhary; Ronald G Victor; Gail D Thomas; Paul J Fadel
Journal:  J Physiol       Date:  2009-09-01       Impact factor: 5.182

4.  Pattern of sympathetic vasomotor activity in a model of hypertension induced by nitric oxide synthase blockade.

Authors:  Lysien I Zambrano; Roberto B Pontes; Michelle L Garcia; Erika E Nishi; Fernando N Nogueira; Elisa M S Higa; Juliana G Cespedes; Cassia T Bergamaschi; Ruy R Campos
Journal:  Physiol Rep       Date:  2019-07

5.  Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.

Authors:  Jeanie Park
Journal:  Cardiol Res Pract       Date:  2012-08-07       Impact factor: 1.866

6.  Blockade of Rostral Ventrolateral Medulla Apelin Receptors Does Not Attenuate Arterial Pressure in SHR and L-NAME-Induced Hypertensive Rats.

Authors:  Philip R Griffiths; Stephen J Lolait; Louise E Pearce; Fiona D McBryde; Julian F R Paton; Anne-Marie O'Carroll
Journal:  Front Physiol       Date:  2018-10-24       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.